Dr. Lal PathLabs Limited (BOM: 539524)
India
· Delayed Price · Currency is INR 2,879.40
+119.30 (4.32%)
At close: Jan 30, 2025
Dr. Lal PathLabs Statistics
Total Valuation
Dr. Lal PathLabs has a market cap or net worth of INR 237.72 billion. The enterprise value is 228.78 billion.
| Market Cap | 237.72B |
| Enterprise Value | 228.78B |
Important Dates
The last earnings date was Wednesday, January 22, 2025.
| Earnings Date | Jan 22, 2025 |
| Ex-Dividend Date | Feb 5, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.05% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 37.00M |
Valuation Ratios
The trailing PE ratio is 57.03.
| PE Ratio | 57.03 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 20.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 54.88 |
| EV / Sales | 9.52 |
| EV / EBITDA | 34.31 |
| EV / EBIT | 43.04 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | n/a |
| Interest Coverage | 22.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 15.31% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.87M |
| Profits Per Employee | 1.02M |
| Employee Count | 4,099 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +16.48% |
| 50-Day Moving Average | 2,953.52 |
| 200-Day Moving Average | 2,971.00 |
| Relative Strength Index (RSI) | 48.32 |
| Average Volume (20 Days) | 5,368 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Lal PathLabs had revenue of INR 24.04 billion and earned 4.17 billion in profits. Earnings per share was 50.01.
| Revenue | 24.04B |
| Gross Profit | 13.88B |
| Operating Income | 5.32B |
| Pretax Income | 5.91B |
| Net Income | 4.17B |
| EBITDA | 6.29B |
| EBIT | 5.32B |
| Earnings Per Share (EPS) | 50.01 |
Balance Sheet
The company has 11.27 billion in cash and 1.99 billion in debt, giving a net cash position of 9.28 billion.
| Cash & Cash Equivalents | 11.27B |
| Total Debt | 1.99B |
| Net Cash | 9.28B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 20.35B |
| Book Value Per Share | 240.44 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 57.71%, with operating and profit margins of 22.11% and 17.34%.
| Gross Margin | 57.71% |
| Operating Margin | 22.11% |
| Pretax Margin | 24.59% |
| Profit Margin | 17.34% |
| EBITDA Margin | 26.17% |
| EBIT Margin | 22.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 24.00, which amounts to a dividend yield of 0.83%.
| Dividend Per Share | 24.00 |
| Dividend Yield | 0.83% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -4.05% |
| Shareholder Yield | -2.96% |
| Earnings Yield | 1.75% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |